Use of mHealth Devices to Screen for Atrial Fibrillation: Cost-Effectiveness Analysis

Abstract

The use of mHealth devices to screen for AF leads to increased costs but also a reduction in the incidence of stroke. In particular, in patients with high CHA₂DS₂-VASc scores, the risk for stroke and death from stroke can be markedly reduced.